Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
DRUG APPROVALS
June 16, 2022
Introduction to Two Recently Approved Insulin Glargine Biosimilars
Two insulin biosimilars for insulin glargine, a subcutaneous long-acting insulin analogue for improving glycemic control, have recently been approved
June 16, 2022
Dispelling Generic Drug Myths and Misconceptions
October 15, 2021
Azstarys in Ora-Blend Single Dose
October 15, 2021
Recent Trends in Approvals of Novel Drugs
October 15, 2021
Review of Selected NMEs 2021
October 15, 2021
New Drug Review 2021
October 16, 2020
New Drug Review 2020
October 16, 2019
Review of Selected NMEs 2019
October 16, 2019
New Drug Review 2019
May 17, 2019
Acute Myeloid Leukemia: From Molecular Pathogenesis to Oral Targeted Therapies
October 16, 2018
Review of Selected NMEs 2018
October 16, 2018
New Drug Review 2018
October 13, 2017
New Drug Review 2017
Load More
X
June 2022
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image